FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912188626> ?p ?o ?g. }

• W2912188626 endingPage "149" @default.
• W2912188626 startingPage "142" @default.
• W2912188626 abstract "Canada is experiencing a new era of harm reduction policymaking and investment. While many provinces and territories are expanding access to these services, harm reduction policy and policymaking varies across the country. The present study, part of the Canadian Harm Reduction Policy Project (CHARPP), described policy actors’ views on formal harm reduction policies in Canada’s 13 provinces and territories. As part of CHARPP’s mixed-method, multiple case study, we conducted qualitative interviews with 75 policy actors, including government officials, health system leaders, senior staff at community organizations, and advocates with self-identified lived experience of using drugs. Interviews were conducted in English or French, and recorded and transcribed verbatim. We used latent content analysis to inductively code the data and generate main findings. NVivo 11 was used to organize the transcripts. Participants expressed divergent views on formal provincial/territorial policies and their impact on availability of harm reduction programs and services. While some identified a need to develop new policies or improve existing ones, others resisted bureaucratization of harm reduction or felt the absence of formal policy was instead, advantageous. Instances where harm reduction was advanced outside of formal policymaking were also described. Previous CHARPP research documented wide variability in quantity and quality of formal harm reduction policies across Canada, and characterized official policy documents as serving largely rhetorical rather than instrumental functions. The present findings highlight diverse ways that actors used their discretion to navigate these weak policy contexts. Participants’ views and experiences sometimes referred to strengthening policy support, but institutionalization of harm reduction was also resisted or rejected. Results suggest that actors adopt a range of pragmatic strategies to advance harm reduction services in response to policy vacuums characteristic of morality policy domains, and challenge assumptions about the utility of formal policies for advancing harm reduction." @default.
• W2912188626 created "2019-02-21" @default.
• W2912188626 creator A5010355899 @default.
• W2912188626 creator A5010956542 @default.
• W2912188626 creator A5011215862 @default.
• W2912188626 creator A5020737644 @default.
• W2912188626 creator A5023703404 @default.
• W2912188626 creator A5037775461 @default.
• W2912188626 creator A5044378251 @default.
• W2912188626 creator A5048473520 @default.
• W2912188626 creator A5049273076 @default.
• W2912188626 creator A5051038309 @default.
• W2912188626 creator A5066615859 @default.
• W2912188626 creator A5072809981 @default.
• W2912188626 date "2019-09-01" @default.
• W2912188626 modified "2023-09-25" @default.
• W2912188626 title "Principles, practice, and policy vacuums: Policy actor views on provincial/territorial harm reduction policy in Canada" @default.
• W2912188626 cites W1503328575 @default.
• W2912188626 cites W1763702562 @default.
• W2912188626 cites W1882180401 @default.
• W2912188626 cites W1973629098 @default.
• W2912188626 cites W1980487808 @default.
• W2912188626 cites W2008986123 @default.
• W2912188626 cites W2013251757 @default.
• W2912188626 cites W2014972770 @default.
• W2912188626 cites W2026357450 @default.
• W2912188626 cites W2039571631 @default.
• W2912188626 cites W2046465059 @default.
• W2912188626 cites W2076598545 @default.
• W2912188626 cites W2079635951 @default.
• W2912188626 cites W2082016536 @default.
• W2912188626 cites W2087864081 @default.
• W2912188626 cites W2097398776 @default.
• W2912188626 cites W2116139155 @default.
• W2912188626 cites W2125565257 @default.
• W2912188626 cites W2126157806 @default.
• W2912188626 cites W2154911495 @default.
• W2912188626 cites W2162567506 @default.
• W2912188626 cites W2315152690 @default.
• W2912188626 cites W2328190647 @default.
• W2912188626 cites W2556785740 @default.
• W2912188626 cites W2565010856 @default.
• W2912188626 cites W2609445649 @default.
• W2912188626 cites W2736795342 @default.
• W2912188626 cites W2752001084 @default.
• W2912188626 cites W2808626879 @default.
• W2912188626 doi "https://doi.org/10.1016/j.drugpo.2018.12.014" @default.
• W2912188626 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30711412" @default.
• W2912188626 hasPublicationYear "2019" @default.
• W2912188626 type Work @default.
• W2912188626 sameAs 2912188626 @default.
• W2912188626 citedByCount "16" @default.
• W2912188626 countsByYear W29121886262019 @default.
• W2912188626 countsByYear W29121886262020 @default.
• W2912188626 countsByYear W29121886262021 @default.
• W2912188626 countsByYear W29121886262022 @default.
• W2912188626 countsByYear W29121886262023 @default.
• W2912188626 crossrefType "journal-article" @default.
• W2912188626 hasAuthorship W2912188626A5010355899 @default.
• W2912188626 hasAuthorship W2912188626A5010956542 @default.
• W2912188626 hasAuthorship W2912188626A5011215862 @default.
• W2912188626 hasAuthorship W2912188626A5020737644 @default.
• W2912188626 hasAuthorship W2912188626A5023703404 @default.
• W2912188626 hasAuthorship W2912188626A5037775461 @default.
• W2912188626 hasAuthorship W2912188626A5044378251 @default.
• W2912188626 hasAuthorship W2912188626A5048473520 @default.
• W2912188626 hasAuthorship W2912188626A5049273076 @default.
• W2912188626 hasAuthorship W2912188626A5051038309 @default.
• W2912188626 hasAuthorship W2912188626A5066615859 @default.
• W2912188626 hasAuthorship W2912188626A5072809981 @default.
• W2912188626 hasConcept C123587114 @default.
• W2912188626 hasConcept C138816342 @default.
• W2912188626 hasConcept C138885662 @default.
• W2912188626 hasConcept C144024400 @default.
• W2912188626 hasConcept C159110408 @default.
• W2912188626 hasConcept C17744445 @default.
• W2912188626 hasConcept C199539241 @default.
• W2912188626 hasConcept C2777363581 @default.
• W2912188626 hasConcept C2778137410 @default.
• W2912188626 hasConcept C3116431 @default.
• W2912188626 hasConcept C39549134 @default.
• W2912188626 hasConcept C41895202 @default.
• W2912188626 hasConcept C51575053 @default.
• W2912188626 hasConcept C529928208 @default.
• W2912188626 hasConcept C71924100 @default.
• W2912188626 hasConcept C94625758 @default.
• W2912188626 hasConceptScore W2912188626C123587114 @default.
• W2912188626 hasConceptScore W2912188626C138816342 @default.
• W2912188626 hasConceptScore W2912188626C138885662 @default.
• W2912188626 hasConceptScore W2912188626C144024400 @default.
• W2912188626 hasConceptScore W2912188626C159110408 @default.
• W2912188626 hasConceptScore W2912188626C17744445 @default.
• W2912188626 hasConceptScore W2912188626C199539241 @default.
• W2912188626 hasConceptScore W2912188626C2777363581 @default.
• W2912188626 hasConceptScore W2912188626C2778137410 @default.
• W2912188626 hasConceptScore W2912188626C3116431 @default.
• W2912188626 hasConceptScore W2912188626C39549134 @default.
• W2912188626 hasConceptScore W2912188626C41895202 @default.

• next